Tokio Marine Asset Management CO LTD Catalent, Inc. Transaction History

Tokio Marine Asset Management CO LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$32.18 - $46.57 $10,651 - $15,414	331 Added 6.16%	5,703 $256,000
Q3 2023 Nov 02, 2023	BUY	$44.2 - $50.2 $5,215 - $5,923	118 Added 2.25%	5,372 $244,000
Q2 2023 Jul 28, 2023	BUY	$31.86 - $67.26 $33,006 - $69,681	1,036 Added 24.56%	5,254 $227,000
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $191,665 - $313,228	4,218 New	4,218 $277,000
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $7,525 - $11,762	104 Added 3.42%	3,147 $228,000
Q2 2022 Aug 09, 2022	BUY	$87.2 - $114.05 $48,657 - $63,639	558 Added 22.45%	3,043 $326,000
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $6,216 - $8,216	66 Added 2.73%	2,485 $276,000
Q4 2021 Jan 26, 2022	SELL	$119.57 - $139.07 $82,383 - $95,819	-689 Reduced 22.17%	2,419 $310,000
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $339,300 - $442,423	3,108 New	3,108 $414,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.